• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

早期帕金森病中脑的纵向变化:通过R2*/磁共振成像估计铁含量

Longitudinal midbrain changes in early Parkinson's disease: iron content estimated from R2*/MRI.

作者信息

Wieler Marguerite, Gee Myrlene, Martin W R Wayne

机构信息

Division of Neurology, University of Alberta, Edmonton, Alberta, Canada.

Department of Biomedical Engineering, University of Alberta, Edmonton, Alberta, Canada.

出版信息

Parkinsonism Relat Disord. 2015 Mar;21(3):179-83. doi: 10.1016/j.parkreldis.2014.11.017. Epub 2014 Nov 29.

DOI:10.1016/j.parkreldis.2014.11.017
PMID:25534153
Abstract

OBJECTIVE

To determine whether, in patients with early Parkinson's disease (PD), longitudinal changes in midbrain iron content are associated with declining motor function over a period of three years.

METHODS

Nineteen untreated subjects with early PD and 13 age- and sex-matched controls were followed clinically for 36 months. MRI with a 3 T magnet was performed at baseline, 18 months and 36 months with a multiple gradient echo sequence designed for rapid single-scan mapping of the proton transverse relaxation rate R2*. R2* was calculated for midbrain and forebrain basal ganglia regions.

RESULTS

A difference in R2* between patients and controls was observed at baseline (p = 0.035) but not at 18 or 36 months in the lateral substantia nigra pars compacta (SNc). Linear regression indicated significant correlations between the change in R2* in the lateral SNc and the change score in UPDRS III (p = 0.008) and the PDQ-39 -mobility sub-score (p = 0.03) from baseline to 36 months. R2* tended to increase in those with more advanced disease and to decrease in those with milder disease.

CONCLUSIONS

High field MRI demonstrates lateral SNc abnormalities that progress over 3 years in early PD consistent with increased iron content in those with more advanced disease, corresponding to the known distribution of neuronal loss occurring in this disorder, and correlating with motor symptomatology. Larger and longer investigations with more precise mapping of iron-containing midbrain structures are needed to fully evaluate the potential of R2* as a biomarker of disease progression in PD.

摘要

目的

确定早期帕金森病(PD)患者中脑铁含量的纵向变化是否与三年期间运动功能下降相关。

方法

对19名未经治疗的早期PD患者和13名年龄及性别匹配的对照者进行了36个月的临床随访。在基线、18个月和36个月时,使用3T磁共振成像仪,采用一种多梯度回波序列进行检查,该序列设计用于快速单扫描质子横向弛豫率R2的映射。计算中脑和前脑基底神经节区域的R2。

结果

在黑质致密部外侧,患者与对照者在基线时R2存在差异(p = 0.035),但在18个月或36个月时无差异。线性回归表明,从基线到36个月,黑质致密部外侧R2的变化与统一帕金森病评定量表第三部分(UPDRS III)的变化评分(p = 0.008)以及帕金森病问卷-39运动亚评分(p = 0.03)之间存在显著相关性。R2*在病情较重者中倾向于升高,在病情较轻者中倾向于降低。

结论

高场磁共振成像显示早期PD患者黑质致密部外侧异常在3年内进展,与病情较重者铁含量增加一致,这与该疾病中已知的神经元丢失分布相对应,并与运动症状学相关。需要进行更大规模、更长时间且对含铁血脑结构进行更精确映射的研究,以充分评估R2*作为PD疾病进展生物标志物的潜力。

相似文献

1
Longitudinal midbrain changes in early Parkinson's disease: iron content estimated from R2*/MRI.早期帕金森病中脑的纵向变化:通过R2*/磁共振成像估计铁含量
Parkinsonism Relat Disord. 2015 Mar;21(3):179-83. doi: 10.1016/j.parkreldis.2014.11.017. Epub 2014 Nov 29.
2
Midbrain iron content in early Parkinson disease: a potential biomarker of disease status.早期帕金森病中脑铁含量:疾病状态的潜在生物标志物
Neurology. 2008 Apr 15;70(16 Pt 2):1411-7. doi: 10.1212/01.wnl.0000286384.31050.b5. Epub 2008 Jan 2.
3
Freezing of gait in early Parkinson's disease: Nigral iron content estimated from magnetic resonance imaging.早期帕金森病步态冻结:通过磁共振成像估计黑质铁含量。
J Neurol Sci. 2016 Feb 15;361:87-91. doi: 10.1016/j.jns.2015.12.008. Epub 2015 Dec 8.
4
Quantitative susceptibility mapping of the midbrain in Parkinson's disease.帕金森病中脑的定量磁化率成像
Mov Disord. 2016 Mar;31(3):317-24. doi: 10.1002/mds.26417. Epub 2015 Sep 12.
5
Quantitative assessment of iron deposition in the midbrain using 3D-enhanced T2 star weighted angiography (ESWAN): a preliminary cross-sectional study of 20 Parkinson's disease patients.采用 3D 增强 T2*加权血管造影术(ESWAN)定量评估中脑铁沉积:20 例帕金森病患者的初步横断面研究。
Magn Reson Imaging. 2013 Sep;31(7):1068-73. doi: 10.1016/j.mri.2013.04.015. Epub 2013 Jun 6.
6
Is R2* a new MRI biomarker for the progression of Parkinson's disease? A longitudinal follow-up.R2* 是否为帕金森病进展的新 MRI 生物标志物?一项纵向随访研究。
PLoS One. 2013;8(3):e57904. doi: 10.1371/journal.pone.0057904. Epub 2013 Mar 1.
7
Quantifying brain iron deposition in patients with Parkinson's disease using quantitative susceptibility mapping, R2 and R2.使用定量磁化率成像、R2和R2*对帕金森病患者脑铁沉积进行定量分析
Magn Reson Imaging. 2015 Jun;33(5):559-65. doi: 10.1016/j.mri.2015.02.021. Epub 2015 Feb 24.
8
Imaging brain iron and diffusion patterns: a follow-up study of Parkinson's disease in the initial stages.脑铁成像与弥散模式:帕金森病早期的随访研究。
Acad Radiol. 2014 Jan;21(1):64-71. doi: 10.1016/j.acra.2013.09.018.
9
Quantitative estimation of regional brain iron with magnetic resonance imaging.磁共振成像对脑内铁的定量评估。
Parkinsonism Relat Disord. 2009 Dec;15 Suppl 3:S215-8. doi: 10.1016/S1353-8020(09)70818-1.
10
Distinct progression pattern of susceptibility MRI in the substantia nigra of Parkinson's patients.帕金森病患者黑质磁共振敏感加权成像的不同进展模式。
Mov Disord. 2018 Sep;33(9):1423-1431. doi: 10.1002/mds.27318. Epub 2018 May 14.

引用本文的文献

1
Neuroimaging Biomarkers in Parkinson's Disease.帕金森病的神经影像学标志物。
Adv Neurobiol. 2024;40:617-663. doi: 10.1007/978-3-031-69491-2_21.
2
Leveraging ultra-high field (7T) MRI in psychiatric research.利用超高场(7T)磁共振成像在精神医学研究中的应用。
Neuropsychopharmacology. 2024 Nov;50(1):85-102. doi: 10.1038/s41386-024-01980-6. Epub 2024 Sep 9.
3
Neuroimaging and fluid biomarkers in Parkinson's disease in an era of targeted interventions.神经影像学和液体生物标志物在靶向干预时代的帕金森病。
Nat Commun. 2024 Jul 5;15(1):5661. doi: 10.1038/s41467-024-49949-9.
4
Iron Deposition in Parkinson's Disease: A Mini-Review.帕金森病中的铁沉积:小型综述。
Cell Mol Neurobiol. 2024 Feb 23;44(1):26. doi: 10.1007/s10571-024-01459-4.
5
How should we be using biomarkers in trials of disease modification in Parkinson's disease?我们应该如何在帕金森病疾病修饰治疗的临床试验中使用生物标志物?
Brain. 2023 Dec 1;146(12):4845-4869. doi: 10.1093/brain/awad265.
6
Clinical and Research MRI Techniques for Assessing Spinal Cord Integrity in Degenerative Cervical Myelopathy-A Scoping Review.评估退行性颈椎脊髓病中脊髓完整性的临床与研究性磁共振成像技术——一项范围综述
Biomedicines. 2022 Oct 18;10(10):2621. doi: 10.3390/biomedicines10102621.
7
Mechanisms of Ferroptosis and Emerging Links to the Pathology of Neurodegenerative Diseases.铁死亡的机制及其与神经退行性疾病病理学的新联系
Front Aging Neurosci. 2022 Jun 28;14:904152. doi: 10.3389/fnagi.2022.904152. eCollection 2022.
8
Combined Application of Quantitative Susceptibility Mapping and Diffusion Kurtosis Imaging Techniques to Investigate the Effect of Iron Deposition on Microstructural Changes in the Brain in Parkinson's Disease.定量磁化率成像与扩散峰度成像技术联合应用于研究铁沉积对帕金森病患者脑微观结构变化的影响
Front Aging Neurosci. 2022 Mar 15;14:792778. doi: 10.3389/fnagi.2022.792778. eCollection 2022.
9
Multimodal brain and retinal imaging of dopaminergic degeneration in Parkinson disease.帕金森病多巴胺能变性的多模态脑和视网膜成像。
Nat Rev Neurol. 2022 Apr;18(4):203-220. doi: 10.1038/s41582-022-00618-9. Epub 2022 Feb 17.
10
Neuromelanin-MRI to Quantify and Track Nigral Depigmentation in Parkinson's Disease: A Multicenter Longitudinal Study Using Template-Based Standardized Analysis.神经黑色素 MRI 定量和跟踪帕金森病中的黑质脱色素:基于模板的标准化分析的多中心纵向研究。
Mov Disord. 2022 May;37(5):1028-1039. doi: 10.1002/mds.28934. Epub 2022 Feb 15.